Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Markus Rechsteiner
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated With Anti-Ctla-4 Antibodies: Association With Overall Survival?
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
JAMA Oncology
Cancer Research
Oncology
Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study
Frontiers in Immunology
Allergy
Immunology
Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy
PLoS ONE
Multidisciplinary
Network Meta-Analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
Oncology and Therapy
Oncology
Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
JAMA Oncology
Cancer Research
Oncology
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
JAMA Surgery
Surgery
Improved Survival With T Cell Clonotype Stability After Anti-Ctla-4 Treatment in Cancer Patients
Science Translational Medicine
Medicine
Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated With Ipilimumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology